Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Lavender Sky Health vs TOM Weight Loss

Lavender Sky Health
Graded #138

Higher grade

vs+2.4000000000000057
TOM Weight Loss
Graded #193

Lower grade

The verdict

Lavender Sky Health takes it — 68.7/100 to 66.3/100.

Lavender Sky Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Lavender Sky Health is a marketplace of about ten compounding pharmacies rather than a single-price provider, each with its own ladder of prepaid tiers and month-to-month plans.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueLavender Sky Health +18
76
58
Dose & formulationLavender Sky Health +2
64
62
Clinical oversightTOM Weight Loss +16
74
90
Labs & monitoringTOM Weight Loss +2
53
55
FulfillmentLavender Sky Health +8
81
73
Contract termsEven
55
55
Lavender Sky Health · left barTOM Weight Loss · right bar

The numbers

MetricLavender Sky HealthTOM Weight Loss
WeighScore68.7/10066.3/100
GradeCC
Scorecard rank#138#193
Semaglutide$139/mo (starting dose, month to month, Southend Pharmacy, compounded)$199/mo (all doses, compounded)
Tirzepatide$149/mo (starting dose, month to month, ReviveRx, compounded)$249/mo (all doses, compounded)
CoverageAll 50 states2 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Lavender Sky Health

Graded #138 · C

Strengths

  • The treatment-plan pricing page publishes every pharmacy's full ladder rather than one headline figure, so the cheaper prepaid tiers are visible alongside the monthly ones
  • A genuine month-to-month starter plan exists with no prepay, and the cheapest of them is what is filed above — Southend for semaglutide, ReviveRx for tirzepatide
  • Compounded plans include the price of the medication, and shipping and supplies are stated as included
  • Both semaglutide and tirzepatide are offered, across roughly ten named compounding pharmacies

Where it loses points

  • This is a marketplace, not one price: every figure belongs to a named pharmacy on a named plan, and the pharmacy and plan have to travel with the number for it to mean anything
  • Most of the ladder is prepaid — Tier plans need 8-10 weeks up front and Extended plans 3-4 months — and only a handful of the pharmacies publish a month-to-month starter plan at all
  • Brand-name plans add a separate $25 monthly treatment-plan fee and explicitly do not include the price of the medication; only the compounded plans include it
  • No price appears on the homepage, and the pricing page is the only place the ladders are published
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products
TOM Weight Loss

Graded #193 · C

Strengths

  • ABOM board-certified physician (Dr. Tran Le, NPI 1194212258, verified ACTIVE)
  • Solo-physician model — every patient sees Dr. Le directly
  • Flat-rate pricing — no dose escalation surcharge
  • LegitScript badge displayed
  • No FDA Warning Letters

Where it loses points

  • Limited geographic footprint — Texas and Utah only
  • No named compounding pharmacy partner disclosed
  • Compounded medications are not FDA-approved
  • Cash-pay only, no insurance

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard